解锁ESCC进展:CCL15-CCR1轴激活了AKT/ERK1/2/c-Jun/CDK2路径
Shengliang He1,2,3, Yunjiu Gou4, Qizhou Bo4
1The First Clinical Medical College of Lanzhou University, Lanzhou University, 730000, China.
Journal of Cancer
|July 31, 2025
概括
化学因子 (C-C动机) 体15 (CCL15) 和它的受体CCR1通过激活CDK2.2促进食道状细胞癌 (ESCC) 的进展. 针对这个CCL15-CCR1轴,可能与Jervine一起,为ESCC提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 食道状细胞癌 (ESCC) 是一个重要的全球健康问题.
- 瘤分泌的CCL15通过CCR1招募巨细胞,帮助免疫逃避和瘤生长.
- 以前,瘤表达的CCL15和CCR1在ESCC进展中的直接作用尚不清楚.
研究的目的:
- 研究CCL15-CCR1轴在ESCC中的直接功能作用.
- 阐明驱动ESCC进展的潜在分子机制.
- 在CCL15-CCR1通路内识别潜在的治疗点.
主要方法:
- 在ESCC组织和细胞系中分析CCL15和CCR1表达.
- 在体外功能测定 (增殖,迁移,入侵) 用复合CCL15和基因淘汰.
- 免疫光,共免疫沉,PCR阵列和ChIP-qPCR测定以确认相互作用和信号通路.
- 对CCR1抑制剂/降解剂进行药物查.
主要成果:
- 在ESCC组织和细胞系中,CCL15和CCR1过度表达.
- 再组合CCL15增强ESCC细胞的增殖,迁移和入侵.
- 抑制CCL15或CCR1可以抑制ESCC的进展,而抑制CCR1可以逆转CCL15的影响.
- CCL15-CCR1轴通过AKT/ERK1/2通路通过c-Jun酸化激活CDK2转录.
- 杰维因被确定为潜在的CCR1降解剂.
结论:
- 在CCL15-CCR1轴直接促进ESCC的进步.
- 该途径涉及通过c-Jun酸化介导的CDK2激活.
- 针对CCL15-CCR1轴,可能与Jervine一起,代表了ESCC的一个有希望的治疗策略.
相关概念视频
MAPK Signaling Cascades
6.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.1K
Mitogens and the Cell Cycle
6.9K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K
Amplifying Signals via Enzymatic Cascade
8.8K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.8K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K


